Washington D.C. – The Board of Pharmacy Specialties (BPS), has approved recommendations from the Compounded Sterile Preparations Pharmacy (BCSCP) Specialty Council to revise the eligibility criteria for the BCSCP certification examination. The revised eligibility criteria will go into effect August
Washington D.C. – The Board of Pharmacy Specialties (BPS), the premier post-licensure certification organization serving the pharmacy profession, announces the results of the 2024 certification and recertification examinations administered via continuous testing. In 2024, a total of 1,854 out of
Washington, D.C. – The Board of Pharmacy Specialties (BPS) is proud to announce the 2025 BPS Awards recipients. The recipients will formally accept their award at a venue of their choosing in 2025. The 2025 Rising Star Award: Lauren Pamulapati,
Washington, D.C. – The Board of Pharmacy Specialties (BPS), the post-licensure certification organization serving the pharmacy profession, issues a call for petition in pharmacogenomics. In January 2025, the BPS Board of Directors reviewed a job analysis (JA; also known as
Washington D.C. – The Board of Pharmacy Specialties (BPS), the premier post-licensure pharmacist certification agency, announces open recruitment for the position of Executive Director, BPS. Previous BPS Executive Director, William M. Ellis, retired in January 2025. The search will be
Washington D.C. – The Board of Pharmacy Specialties (BPS) has released a request for proposals (RFP) to provide a professional development program (PDP) for the recertification of board-certified pain management pharmacists (BCPMP). This RFP concerns continuing pharmacy education (CPE) and